ABCG2 and in situ carcinoma: Cheng W. et al. showed that miR-199a-3p and miR-199a-5p overexpression significantly decreased chemoresistance of cancer-initiating cells (CICs) to CIS, PAC, and DOX and reduced mRNA expression of the multidrug resistance gene ABCG2 in vivo [76].